Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

TIVIDENOFUSP ALFA-EKNM

FDA · BLA · 2026-03-24

AgencyFDA
Submission typeBLA
Action date2026-03-24
BrandAVLAYAH
SponsorDENALI THERAPEUTICS INC.
RoutePOWDER,FOR SOLUTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T10:41:02.490Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:TIVIDENOFUSP ALFA-EKNM:2026-03-24

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Same entity, elsewhere in the suite